ExonHit Announces Successful Completion of the First Phase of EHT Dx14 Ongoing Clinical Validation
31-Mar-2011 -
ExonHit Therapeutics announced successful completion of the first phase of the validation study of EHT Dx14, a new transcriptomic signature allowing to differentiate, at molecular level, benign breast tumors from malignant ones.“These very promising first results confirm EHT Dx14 capability to ...
breast cancer
diagnostic tests